NDC 11673-901 - Maximum Strength Daytime Severe and Nighttime Cold and Flu
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 11673-901
- Manufacturer
- TARGET Corporation | TIME CAP LABORATORIES, INC. | MARKSANS PHARMA LIMITED
- Effective date
- 2023-10-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| 748L Maximum Strength Daytime Severe Nighttime Cold & Flu | TARGET Corporation | TIME CAP LABORATORIES, INC. | MARKSANS PHARMA LIMITED | 2023-10-30 | HUMAN OTC DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nighttime SEVERE | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HYDROCHLORIDE | H E B | 0a178114-0748-4a92-9b60-a7a0a8b72287 | 2025-08-26 | Warnings | 9D2RTI9KYH 04JA59TNSJ 362O9ITL9D |
| good neighbor pharmacy migraine relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Amerisource Bergen | 201f101a-3b53-4349-896c-6b86cdd9b831 | 2025-08-26 | Warnings | 362O9ITL9D |
| Hydrocodone Bitartrate and Acetaminophen | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | Camber Pharmaceuticals, Inc. | 4d5bfd3a-3793-4d24-aedd-c04fa34ea736 | 2025-08-26 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| pain relief | ACETAMINOPHEN | Safeway | 0e0a73f9-8c18-41fd-812e-8be20287e77a | 2025-08-26 | Warnings | 362O9ITL9D |
| good sense pain relief arthritis pain | ACETAMINOPHEN | Bryant Ranch Prepack | 7b0b07f6-242a-4e1a-ab39-84f0334d4716 | 2025-08-26 | Warnings | 362O9ITL9D |
| CAREONE DUAL ACTION | ACETAMINOPHEN, IBUPROFEN | Retail Business Services, LLC | 76302cb3-0371-49ce-85d8-5f3785c370b0 | 2025-08-25 | Warnings | 362O9ITL9D |
| Topcare Pain Relief | ACETAMINOPHEN | Sixarp, LLC | 2e20be17-2b6c-1a07-e063-6394a90acdd3 | 2025-08-25 | Warnings | 362O9ITL9D |
| Adult Bisolvine Adult | GUAIFENESIN, DEXTROMETHORPHAN | MENPER DISTRIBUTORS INC. | 8cde5e39-a338-45af-b847-3823627f29c5 | 2025-08-25 | Warnings | 9D2RTI9KYH 495W7451VQ |
| Pain Reliever PM Extra Strength | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | Strategic Sourcing Services LLC | 997eb228-09cb-47ad-acbb-363b05c67635 | 2025-08-25 | Warnings | TC2D6JAD40 362O9ITL9D |
| QUALITY CHOICE NIGHTTIME SLEEP AID | DIPHENHYDRAMINE HYDROCHLORIDE | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | 3ce00c99-1a9b-41f1-a99a-35e03730dff0 | 2025-08-23 | Warnings | TC2D6JAD40 |
| Foaming Facial Cleanser | GLYCERIN, NIACINAMIDE | Guangzhou Danting Bath&Body Care Industry Co. Ltd | 396c1db9-a5d3-cc82-e063-6294a90a90bb | 2025-08-23 | Warnings | PDC6A3C0OX |
| DIPHENHYDRAMINE HYDROCHLORIDE | DIPHENHYDRAMINE HYDROCHLORIDE | Micro Labs Limited | c2981222-1671-4ecd-a5a2-286f0663f1ae | 2025-08-23 | Warnings, Adverse reactions | TC2D6JAD40 |
| QUALITY CHOICE Childrens Allergy Relief DYE FREE | DIPHENHYDRAMINE HYDROCHLORIDE | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | 644f39d8-7cd6-43dd-9265-546d01d32e8c | 2025-08-22 | Warnings | TC2D6JAD40 |
| SanaTos Multi Symptom | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCI | Pharmadel LLC | df260190-89e7-b338-e053-2995a90a32cb | 2025-08-22 | Warnings | 9D2RTI9KYH 04JA59TNSJ 362O9ITL9D 495W7451VQ |
| Geri-Dryl allergy relief | DIPHENHYDRAMINE HCL | VerityRx | 9ca6c0f8-71d1-4953-8e98-3311c4664011 | 2025-08-22 | Warnings | TC2D6JAD40 |
| SU PHEDRINE PE Non-Drowsy, Maximum Strength | PHENYLEPHRINE HCL | Salado Sales, Inc. | 9056fa58-d6aa-4df5-97e0-9be3f2332f86 | 2025-08-22 | Warnings | 04JA59TNSJ |
| Refresh RELIEVA PF | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | Allergan, Inc. | d5d3df4a-a311-4f2d-9a24-edfec1a6c9f9 | 2025-08-22 | Warnings | PDC6A3C0OX |
| Refresh Optive | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN | Allergan, Inc. | 37e99aa8-02d6-4efb-a862-90bc7fcd5ca5 | 2025-08-22 | Warnings | PDC6A3C0OX |
| Exchange Select Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Army & Air Force Exchange Service | 6c32af3e-5b60-4e3e-95c2-ada37a7d3b2a | 2025-08-22 | Warnings | 04JA59TNSJ |
| Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Padagis Israel Pharmaceuticals Ltd | 43826c68-0a20-460d-a7b5-f3e12395a7d0 | 2025-08-22 | Warnings | 04JA59TNSJ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.